Searched for
EMCURE PHARMA Q2 RESULTS
Emcure Pharma shares hit 10% upper circuit after FY27 guidance hike; Jefferies raises target price by 8%Emcure Pharma shares hit a 10% upper circuit after strong Q2 FY27 results prompted the company to raise its full-year growth guidance. Brok...- Emcure Pharma Q2 Results: Profit jumps 29% to Rs 325 croreEmcure Pharmaceuticals Ltd has posted a remarkable consolidated net profit of Rs 325.06 crore for the September quarter, reflecting substan...
- NSE Q2 Results: Profit jumps 23% to Rs 2,578 crore, revenue rises 9%NSE Q2 Results: The National Stock Exchange of India (NSE) reported a 23% year-on-year (YoY) increase in its consolidated profit after tax ...
- Emcure Pharma shares jump 7% after Q2 profit rises 29% YoY to Rs 325 croreEmcure Pharmaceuticals shares rose up to 7.3% after the company reported a 29.3% year-on-year increase in Q2 FY27 profit to Rs 325.1 crore....
- SBI Q2 Results: Standalone profit rises 14% YoY to Rs 23,038 crore, NII jumps 15%SBI Q2 Results: Net interest income in the reporting period increased 15% YoY to Rs 49,143 crore.
- ITC Q2 Results: Profit falls 18% to Rs 4,229 crore, revenue rises 5%ITC Q2 Results: ITC Ltd reported an 18.5% decline in consolidated net profit for the September quarter on Monday as a sharp fall in earning...
- Reliance Industries Q2 Results: Profit shoots up 41% YoY to Rs 25,548 crore, revenue surges 29%Reliance Industries Q2 Results: Mukesh Ambani-led Reliance Industries Ltd (RIL) on Friday reported a 41% year-on-year (YoY) growth in conso...
- Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional chargesSun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported...
- RIL Q2 Results Preview: Profit outlook brightens as O2C business set to drive growthReliance Industries is expected to report 15-17% year-on-year growth in September-quarter EBITDA, driven by a sharp recovery in its oil-to-...
- Trent Q2 Results: Cons profit jumps 25% YoY to Rs 468 crore; revenue climbs 22%Trent Q2 Results: Trent reported a 25.3% year-on-year rise in Q2 FY27 consolidated net profit to Rs 468 crore, while revenue grew 21.9% to ...
- IndiGo Q2 Results: Loss narrows YoY to Rs 1,879 crore; revenue rises 26%IndiGo Q2 Results: Budget airline IndiGo reported narrowing of its consolidated loss to Rs 1,879 crore in the second quarter of FY27, compa...
- Hyundai Motor India Q2 Results: Standalone profit falls 24% YoY to Rs 1,189 crore, but revenue rises 18%Hyundai Motors India has reported a standalone net profit of Rs 1,189 crore for Q2 FY27, reflecting a notable decrease of 24% compared to R...
- Adani Ports Q2 Results: Net profit jumps 17% YoY to Rs 3,622 crore; revenue up 24%Adani Ports Q2 Results: Adani Ports reported a 17% year-on-year rise in Q2 FY27 net profit to Rs 3,622 crore, while revenue grew 24% to Rs ...
- Larsen & Toubro Q2 Results: Profit surges 33% YoY to Rs 5,202 crore, revenue grows 16%L&T Q2 Results: Larsen & Toubro announced significant financial results for the quarter ended September 30, 2026. The company reported a 33...
- Cipla Q2 Results: Profit falls 35% YoY to Rs 878 crore; revenue slips 2%Cipla reported a 35% drop in consolidated net profit for Q2FY27, which stood at Rs 878 crore. The company also experienced a 2.4% year-on-y...
- D-Street in gloomy mood, but Kotak sees 3 triggers for rebounds and adds 5 midcap stocks to portfolioDalal Street faces significant market challenges, leading Kotak Institutional Equities to spotlight selective stock value. With large-cap s...
- Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 croreMankind Pharma shares jumped nearly 8% after the company reported a 38% year-on-year rise in Q2 profit to Rs 716 crore. Revenue grew 17%, s...
- Paytm Q2 Results: Profit rockets 976% YoY to Rs 226 crore, revenue jumps 28%Paytm Q2 Results: Fintech major Paytm on Monday reported 976% year-on-year (YoY) growth in its consolidated net profit at Rs 226 crore. The...
- Mankind Pharma shares key business developments from Q2 & H1 of FY27The company outperformed the market by 1.1 times in both chronic and acute therapies. Cardiac and anti-diabetes brands registered growth of...
- Infosys Q2 Results: Profit rises 6% YoY to Rs 7,823 crore; co lowers revenue guidanceInfosys Q2 Results: IT services major Infosys Ltd on Friday reported 6% year-on-year (YoY) growth in its consolidated net profit at Rs 7,82...
Load More
